X

Vous n'êtes pas connecté

Maroc Maroc - WESTERNSTANDARDONLINE.COM - A La Une - 13/Sep 17:50

U.S. lawmakers call out FDA for slow ‘smoke-free’ product review amid growing illegal market

U.S. lawmakers and health groups are upset about how the Food and Drug Administration (FDA) is handling e-cigarettes and other smoke-free products.

Articles similaires

Sorry! Image not available at this time

U.S. lawmakers call out FDA for slow ‘smoke-free’ product review amid growing illegal market

westernstandardonline.com - 13/Sep 17:50

U.S. lawmakers and health groups are upset about how the Food and Drug Administration (FDA) is handling e-cigarettes and other smoke-free products.

Sorry! Image not available at this time

Most Tobacco Instagram Posts Do Not Adhere to FDA Warning Requirements

drugs.com - 16/Sep 16:09

MONDAY, Sept. 16, 2024 -- Most nicotine brand Instagram posts do not adhere to U.S. Food and Drug Administration (FDA) health warning requirements for...

Sorry! Image not available at this time

FDA to Investigate Safety of Toxic Metals in Tampons

drugs.com - 11/Sep 11:09

WEDNESDAY, Sept. 11, 2024 -- The U.S. Food and Drug Administration announced Tuesday that it will launch an independent review into any possible...

Sorry! Image not available at this time

Travere Therapeutics Announces Full FDA Approval of Filspari (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy

drugs.com - 05/Sep 05:09

SAN DIEGO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the U.S. Food and Drug Administration...

Sorry! Image not available at this time

Travere Therapeutics Announces Full FDA Approval of Filspari (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy

drugs.com - 05/Sep 05:09

SAN DIEGO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the U.S. Food and Drug Administration...

Sorry! Image not available at this time

KalVista Announces FDA Acceptance of New Drug Application for Sebetralstat for Oral On-Demand Treatment of Hereditary Angioedema

drugs.com - 03/Sep 20:09

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--Sep. 3, 2024-- KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the U.S....

2 women die in Georgia after they couldn't access legal abortions and timely care

rawstory.com - 16/Sep 21:50

by Kavitha SuranaProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one...

Sorry! Image not available at this time

Tremfya (guselkumab) Receives U.S. FDA Approval for Adults with Moderately to Severely Active Ulcerative Colitis

drugs.com - 13/Sep 07:09

HORSHAM, Pa. (September 11, 2024) – Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has approved...

Sorry! Image not available at this time

Tremfya (guselkumab) Receives U.S. FDA Approval for Adults with Moderately to Severely Active Ulcerative Colitis

drugs.com - 13/Sep 07:09

HORSHAM, Pa. (September 11, 2024) – Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has approved...

Sorry! Image not available at this time

Warning labels planned on foods, drinks to address obesity: U.S. FDA

thestar.com.my - 13/Sep 17:54

NEW YORK, Sept. 13 (Xinhua) -- The U.S. Food and Drug Administration (FDA) plans to propose labeling this fall for the front of food and drink...